Angiotensin converting enzyme inhibitors and interstage failure in infants with hypoplastic left heart syndrome

Congenital Heart Disease
Doris P YimgangGeoffrey L Rosenthal

Abstract

Angiotensin converting enzyme inhibitors are commonly prescribed medications after the Norwood procedure. There are little data that can be used to determine if angiotensin converting enzyme inhibitors improve interstage outcomes in children with single ventricle defects. The objective of this study was to investigate the relationship between angiotensin converting enzyme inhibitors and interstage failure among infants born with hypoplastic left heart syndrome. We conducted a retrospective cohort study using data from the National Pediatric Cardiology Quality Improvement Collaborative database (collected between 2008 and 2015). We used logistic regression models to assess the exposure-outcome associations and propensity score matching to account for differences in baseline patient characteristics associated with use of angiotensin converting enzyme inhibitors. A total of 1 487 neonates participated in the study. Thirty-nine percent of patients were prescribed angiotensin converting enzyme inhibitors after the Norwood procedure; 11% experienced interstage failure (death, heart transplantation, and not being a candidate for the second-stage surgery). Before propensity score matching, patients receiving angiotensin converting enzy...Continue Reading

References

Dec 15, 1996·American Journal of Epidemiology·L BlaisS Suissa
Feb 24, 2006·Paediatric Drugs·Kazuo Momma
Feb 14, 2007·Circulation·Paul KhairyLise-Andrée Mercier
Aug 11, 2007·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Marc B Lande, Joseph T Flynn
Jul 29, 2008·The Journal of Pediatrics·Mark D RellerAdolfo Correa
Aug 18, 2009·Lancet·David J BarronWilliam J Brawn
Jul 14, 2010·Circulation·Daphne T HsuUNKNOWN Pediatric Heart Network Investigators
Jun 24, 2011·Congenital Heart Disease·Brady S MoffettChristopher J Petit
Jan 4, 2012·Journal of the American College of Cardiology·Jeffrey A FeinsteinGerard R Martin
Nov 20, 2012·Congenital Heart Disease·Sunil J GhelaniRussell R Cross
Jun 11, 2015·Circulation. Cardiovascular Quality and Outcomes·Jeffrey B AndersonUNKNOWN National Pediatric Cardiology Quality Improvement Collaborative
Jan 19, 2016·Heart, Lung & Circulation·Thomas G WilsonYves d'Udekem
Mar 30, 2017·The Annals of Thoracic Surgery·Charles F EvansGeoffrey L Rosenthal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Pediatrics
Jeffrey B AndersonNational Pediatric Cardiology Quality Improvement Collaborative
Congenital Heart Disease
Jeffrey B AndersonNational Pediatric Cardiology Quality Improvement Collaborative
© 2022 Meta ULC. All rights reserved